M. B. Bertrand, J. P. Wolfe / Tetrahedron 61 (2005) 6447–6459
6457
a pale yellow oil. This product was isolated as a ca 3:1
mixture of diastereomers. Data are for the mixture. 1H NMR
(500 MHz, CDCl3) d 7.90–7.79 (m, 2H), 7.17 (s, br, 2H),
5.72–5.57 (m, 1H), 4.99–4.86 (m, 2H), 4.06–2.83 (m, br,
3H), 2.76–2.48 (m, 2H), 2.07–1.88 (m, 4H), 1.57–1.40 (m,
18H), 1.27–1.11 (m, 1H); 13C NMR (125 MHz, CDCl3) d
166.0, 157.5, 154.7, 149.5, 146.2, 143.8, 136.4, 130.2,
129.7, 116.3, 116.2, 81.0, 79.4, 77.6, 77.2, 76.9, 58.7, 52.7,
52.1, 51.7, 41.8, 41.0, 40.1, 37.9, 37.7, 37.3, 37.0, 36.3,
35.6, 34.9, 28.8, 28.4; IR (film) 2976, 1712, 1694,
1395 cmK1. Anal. Calcd for C24H35NO4: C, 71.79; H,
8.79; N, 3.49. Found: C, 71.60; H, 8.75; N, 3.45.
pyrrolidin-1-yl]ethanone (29). The reaction of 72 mg
(0.5 mmol) of 21 with 4-bromochlorobenzene (106 mg,
0.55 mmol), dpe-phos (10.8 mg, 0.02 mmol, 4 mol%) and
NaOtBu (58 mg, 1.00 mmol) was conducted following
general procedure B. 1H NMR analysis of the crude product
showed the formation of the desired product as a 10:1
mixture of diastereomers. The minor diastereomer was
separated upon chromatographic purification to afford
69.4 mg (61%) of the title compound as a pale yellow oil
with O20:1 dr. Data are for the major diastereomer, which
was found to exist as a 7:3 mixture of rotamers as judged by
1H NMR analysis. 1H NMR (500 MHz, CDCl3) d 7.27–7.16
(m, 2H), 7.12–7.00 (m, 2H), 3.86–3.78 (m, 0.7H), 3.71–3.60
(m, 0.3H), 3.55–3.48 (m, 0.3H), 3.47–3.29 (m, 1H), 3.26–
3.16 (m, 0.7H), 3.08–2.98 (m, 0.7H), 2.81–2.73 (m, 0.3H),
2.72–2.57 (m, 1H), 2.14–2.08 (m, 0.3H), 2.07–1.95 (m,
3.1H), 1.92–1.84 (m, 1.6H), 1.52–1.38 (m, 1H), 0.89–0.80
(m, 3H); 13C NMR (125 MHz, CDCl3) d 169.8, 169.7,
137.5, 136.5, 132.8, 132.1, 131.1, 130.7, 129.1, 128.6, 67.4,
65.3, 46.9, 44.1, 40.6, 37.7, 37.2, 35.6, 31.4, 29.1, 23.2,
22.2, 19.8, 19.3; IR (film) 2961, 1641, 1417 cmK1. MS
(ESI) 274.0969 (274.0975 calcd for C14H18ClNO, MC
NaC).
4.3.15. (G)-(2R,3S)-3-Methyl-2-naphthalen-2-ylmethyl-
pyrrolidine-1-carboxylic acid tert-butyl ester (27). The
reaction of 100 mg (0.5 mmol) of 20 with 2-bromonaphtha-
lene (124 mg, 0.60 mmol), dpe-phos (10.8 mg, 0.02 mmol,
4 mol%) and NaOtBu (96 mg, 1.00 mmol) was conducted
1
following general procedure A. H NMR analysis of the
crude product showed the formation of the desired product
as a 10:1 mixture of diastereomers. The minor diastereomer
was separated upon chromatographic purification to afford
106 mg (65%) of the title compound as a white solid with
O20:1 dr; mp 107 8C. Data are for the major diastereomer,
which was found to exist as a 1:1 mixture of rotamers as
judged by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) d
7.85–7.73 (m, 3H), 7.62 (d, JZ16.3 Hz, 1H), 7.50–7.28 (m,
3H), 3.78–3.60 (m, 1H), 3.61–3.38 (m, 1H), 3.33–3.08 (m,
2H), 2.96–2.73 (m, 1H), 2.15–2.09 (m, 1H), 1.98–1.80 (m,
1H), 1.53 (s, 9H), 1.49–1.34 (m, 1H), 0.84 (s, br, 3H); 13C
NMR (125 MHz, CDCl3) d 155.0, 136.8, 133.7, 132.3,
128.6, 128.2, 128.0, 127.8, 127.7, 126.2, 126.0, 125.5,
125.4, 79.6, 79.5, 66.0, 65.7, 45.7, 45.0, 40.6, 39.1, 37.0,
36.1, 31.3, 30.4, 28.8, 19.6, 19.4 (seven sets of carbons are
4.3.18. (G)-(3aR,6S,6aS)-6-Biphenyl-4-yl-hexahydro-
cyclopenta[b]pyrrole-1-carboxylic acid tert-butyl ester
(30). Reaction of 53 mg (0.25 mmol) of 22 with 4-bromo-
biphenyl (64 mg, 0.28 mmol), xantphos (5.8 mg,
0.01 mmol, 4 mol%) and NaOtBu (36 mg, 0.38 mmol)
following general procedure A afforded 42.8 mg (47%) of
the title compound as a white solid; mp 128 8C. This
compound was found to exist as a 3:2 mixture of rotamers as
judged by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) d
7.55–7.34 (m, 6H), 7.32–7.16 (m, 3H), 4.54–4.30 (m, 1H),
3.83–3.71 (m, 0.6H), 3.55–3.17 (m, 1.4H), 3.10–2.78 (m,
2H), 2.12–1.98 (m, 1H), 1.97–1.60 (m, 5H), 1.21–0.89 (m,
9H); 13C NMR (125 MHz, CDCl3) d 154.5, 141.6, 141.2,
139.4, 129.6, 128.9, 127.2, 127.1, 127.0, 126.6, 94.6, 79.0,
65.4, 52.3, 51.2, 47.8, 43.5, 42.5, 34.2, 33.7, 32.4, 32.2,
31.8, 28.4, 27.9 (thirteen sets of carbons are incidentally
equivalent); IR (film) 2952, 1689, 1392 cmK1. MS (ESI)
386.2105 (386.2096 calcd for C24H29NO2, MCNaC).
incidentally equivalent); IR (film) 2964, 1692, 1396 cmK1
.
MS (ESI) 348.1943 (348.1939 calcd for C21H27NO2, MC
NaC).
4.3.16. (G)-(2R,3S)-2-(4-tert-Butylbenzyl)-3-methyl-
pyrrolidine-1-carboxylic acid tert-butyl ester (28). The
reaction of 100 mg (0.5 mmol) of 20 with 4-bromo-tert-
butylbenzene (105 mL, 128 mg, 0.60 mmol), dpe-phos
(10.8 mg, 0.02 mmol, 4 mol%) and NaOtBu (96 mg,
1.00 mmol) was conducted following general procedure
A. 1H NMR analysis of the crude product showed the
formation of the desired product as a 10:1 mixture of
diastereomers. The minor diastereomer was separated upon
chromatographic purification to afford 97.4 mg (59%) of the
title compound as a pale yellow oil with O20:1 dr. Data are
for the major diastereomer, which was found to exist as a 3:2
4.3.19. (G)-(3aR,6S,6aS)-1-(6-Naphthalen-2-yl-hexa-
hydrocyclopenta[b]pyrrol-1-yl) ethanone (31). Reaction
of 78 mg (0.25 mmol) of 23 with 2-bromonaphthalene
(114 mg, 0.55 mmol), nixantphos (13.8 mg, 0.025 mmol,
5 mol%), Pd2(dba)3 (11.4 mg, 0.0125 mmol, 2.5 mol%) and
NaOtBu (58 mg, 0.60 mmol) following general procedure B
afforded 85 mg (61%) of the title compound as a pale yellow
oil. This compound was found to exist as a 7:3 mixture of
rotamers as judged by 1H NMR analysis. 1H NMR
(400 MHz, CDCl3) d 7.82–7.69 (m, 3H), 7.57 (s, 1H),
7.48–7.34 (m, 2H), 7.28–7.24 (m, 1H), 4.90 (t, JZ8.6 Hz,
0.3H), 4.43 (t, JZ7.0 Hz, 0.7H), 4.14–4.06 (m, 0.70H), 3.54
(q, JZ8.1 Hz, 0.3H), 3.48–3.20 (m, 2H), 3.13–3.04 (m,
0.7H), 2.92–2.82 (m, 0.3H), 2.17–1.92 (m, 4H), 1.85–1.72
(m, 2H), 1.64 (s, 0.6H), 1.11 (s, 2.4H); 13C NMR (100 MHz,
CDCl3) d 170.6, 168.8, 139.2, 138.2, 133.6, 133.5, 132.7,
132.4, 128.31, 128.29, 128.1, 127.91, 127.90, 129.86,
127.81, 127.2, 127.0, 126.6, 126.4, 125.9, 125.8, 125.3,
67.0, 65.2, 53.4, 49.9, 49.1, 47.4, 44.0, 42.3, 33.7, 32.6,
32.4, 32.3, 32.2, 31.4, 22.5, 21.8; IR (film) 2950, 1638,
1
1
mixture of rotamers as judged by H NMR analysis. H
NMR (500 MHz, CDCl3) d 7.35–7.25 (m, 2H), 7.16–7.06
(m, 2H), 3.69–3.37 (m, 2H), 3.31–2.92 (m, 2H), 2.76–2.56
(m, 1H), 2.05 (s, br, 1H), 1.97–1.79 (m, 1H), 1.51 (s, 9H),
1.45–1.35 (m, 1H), 1.32 (s, 9H), 0.88 (d, JZ6.8 Hz, 3H);
13C NMR (125 MHz, CDCl3) d 155.0, 149.2, 149.0, 136.1,
129.5, 129.3, 125.5, 125.3, 79.4, 79.1, 66.1, 65.6, 45.6, 45.0,
39.9, 38.5, 37.1, 36.0, 34.6, 31.6, 31.2, 30.4, 28.8, 19.7, 19.5
(five sets of carbons are incidentally equivalent); IR (film)
2963, 1696, 1395 cmK1. MS (ESI) 354.2402 (354.2409
calcd for C21H33NO2, MCNaC).
4.3.17. (G)-(2R,3S)-1-[2-(4-Chlorobenzyl)-3-methyl